AIRLINK 66.80 Increased By ▲ 2.21 (3.42%)
BOP 5.67 Increased By ▲ 0.07 (1.25%)
CNERGY 4.63 Decreased By ▼ -0.09 (-1.91%)
DFML 22.32 Increased By ▲ 1.56 (7.51%)
DGKC 69.76 Decreased By ▼ -1.64 (-2.3%)
FCCL 19.62 Decreased By ▼ -0.33 (-1.65%)
FFBL 30.20 Decreased By ▼ -0.25 (-0.82%)
FFL 9.90 Decreased By ▼ -0.15 (-1.49%)
GGL 10.05 No Change ▼ 0.00 (0%)
HBL 115.70 Increased By ▲ 4.70 (4.23%)
HUBC 130.51 Decreased By ▼ -0.33 (-0.25%)
HUMNL 6.74 Decreased By ▼ -0.11 (-1.61%)
KEL 4.35 Decreased By ▼ -0.04 (-0.91%)
KOSM 4.80 Increased By ▲ 0.46 (10.6%)
MLCF 37.19 Decreased By ▼ -0.56 (-1.48%)
OGDC 133.55 Decreased By ▼ -0.30 (-0.22%)
PAEL 22.60 Increased By ▲ 0.03 (0.13%)
PIAA 26.70 Decreased By ▼ -0.85 (-3.09%)
PIBTL 6.25 Decreased By ▼ -0.06 (-0.95%)
PPL 113.95 Decreased By ▼ -1.00 (-0.87%)
PRL 27.15 Decreased By ▼ -0.07 (-0.26%)
PTC 16.13 Decreased By ▼ -0.37 (-2.24%)
SEARL 59.70 Decreased By ▼ -1.00 (-1.65%)
SNGP 66.50 Increased By ▲ 1.35 (2.07%)
SSGC 11.21 Decreased By ▼ -0.14 (-1.23%)
TELE 8.94 Decreased By ▼ -0.03 (-0.33%)
TPLP 11.34 Increased By ▲ 0.09 (0.8%)
TRG 69.36 Increased By ▲ 0.31 (0.45%)
UNITY 23.45 Increased By ▲ 0.01 (0.04%)
WTL 1.36 Decreased By ▼ -0.03 (-2.16%)
BR100 7,312 Decreased By -12.8 (-0.17%)
BR30 24,105 Increased By 47 (0.2%)
KSE100 70,484 Decreased By -60.9 (-0.09%)
KSE30 23,203 Increased By 11.5 (0.05%)

Moderna Inc

Moderna testing new COVID-19 vaccine as potential booster shot

Moderna testing new COVID-19 vaccine as potential booster shot

  • The early-stage study will assess the safety and immunogenicity of mRNA-1283 at three dose levels, and will be given to healthy adults either as a single dose or in two doses 28 days apart, the company said.
  • Last week, Moderna began dosing the first participants in a study testing its COVID-19 booster vaccine candidates.
Updated 15 Mar, 2021 09:25pm
Merck to help make Johnson & Johnson's COVID-19 vaccine
Business & Finance

Merck to help make Johnson & Johnson's COVID-19 vaccine

  • After scrapping development of its own COVID-19 vaccine candidates in January, Merck last month said it was working on a deal to open up its manufacturing capacity to other vaccine makers.
  • J&J is shipping about four million doses of its vaccine in the United States this week, but the next shipments hinge on when its new, larger manufacturing plant receives regulatory approvals.
Published 02 Mar, 2021 08:34pm
Japanese shares gain
Markets

Japanese shares gain

TOKYO: Japanese shares rose on Monday, erasing early losses, led by tech and pharma stocks as US futures rose on...
Published 26 Jan, 2021 05:05am
Britain approves Moderna's COVID-19 vaccine for use
World

Britain approves Moderna's COVID-19 vaccine for use

  • Three COVID-19 vaccines have now been approved for use in Britain, with Pfizer/BioNTech's shot and one developed by Oxford University and AstraZeneca already being rolled out.
  • We have already vaccinated nearly 1.5 million people across the UK and Moderna's vaccine will allow us to accelerate our vaccination programme
Published 08 Jan, 2021 06:54pm
Britain approves Moderna's COVID-19 vaccine for use
Business & Finance

Britain approves Moderna's COVID-19 vaccine for use

  • Three COVID-19 vaccines have now been approved for use in Britain, with Pfizer//BioNTech's shot and one developed by Oxford University and AstraZeneca already being rolled out.
  • Moderna's vaccine was 94% effective in preventing disease in late-stage clinical trials.
Published 08 Jan, 2021 06:00pm
Israel authorises use of Moderna's COVID-19 vaccine
World

Israel authorises use of Moderna's COVID-19 vaccine

  • Ministry of Health of Israel has secured 6 million doses and first deliveries (are) expected to begin in January.
  • Israeli Health Minister Yuli Edelstein said he had no knowledge of shipments arriving this month.
Published 05 Jan, 2021 05:31pm